Revenue YoY
—
Operating Income YoY
-12.65%
Net Income YoY
-8.60%
Net Margin Δ
—
Net income bridge for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: −$2.33M-8.60%
Profit bridge breakdown for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | −$27.13M | — |
| Revenue | $0.00 | 0.0% |
| Cost of Revenue | $0.00 | 0.0% |
| Operating Expenses | −$3.53M | -151.7% |
| Other Income / Expense | $1.20M | +51.7% |
| Income Tax | $0.00 | 0.0% |
| Net Loss | −$29.46M | — |
- Prior Net Income−$27.13M
- Revenue$0.00
- Cost of Revenue$0.00
- Operating Expenses−$3.53M
- Other Income / Expense$1.20M
- Income Tax$0.00
- Net Loss−$29.46M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement